{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T11:51:57Z","timestamp":1785498717852,"version":"3.56.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.ijrobp.2016.12.035","type":"journal-article","created":{"date-parts":[[2017,1,7]],"date-time":"2017-01-07T14:45:44Z","timestamp":1483800344000},"page":"1040-1050","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement"],"prefix":"10.1016","volume":"97","author":[{"given":"Brian","family":"Bingham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Orton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Boothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Jessica","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Poppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2016.12.035_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1471-0528.1989.tb03341.x","article-title":"Revised FIGO staging for gynaecological cancer","volume":"96","author":"Shepherd","year":"1989","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib3","series-title":"AJCC cancer staging manual","first-page":"395","year":"2010"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GRF.0b013e3182185baa","article-title":"Revised FIGO staging system for endometrial cancer","volume":"54","author":"Lewin","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib6","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/0360-3016(91)90745-P","article-title":"Survival and failure analysis in stage II endometrial cancer using the revised 1988 FIGO staging system","volume":"21","author":"Reisinger","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1046\/j.1525-1438.2001.01061.x","article-title":"Clinical behavior of 203 stage II endometrial cancer cases: The impact of primary surgical approach and of adjuvant radiation therapy","volume":"11","author":"Sartori","year":"2001","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib8","first-page":"13","article-title":"Whole abdominal radiotherapy versus combination chemotherapy with doxorubicin and cisplatin in advanced endometrial carcinoma (phase III): Gynecologic Oncology Group Study No. 122","volume":"19","author":"Randall","year":"1995","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ygyno.2016.03.021","article-title":"Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: Patterns of care and impact on overall survival","volume":"141","author":"Boothe","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.rpor.2014.09.003","article-title":"The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre","volume":"20","author":"Arenas","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib11","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/jcb.2015.50877","article-title":"The impact of a vaginal brachytherapy boost to pelvic radiation in stage III endometrial cancer","volume":"7","author":"Huddleston","year":"2015","journal-title":"J\u00a0Contemp Brachytherapy"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib12","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/IGC.0b013e3182978328","article-title":"Adjuvant therapy in stage III endometrial cancer: Treatment outcomes and survival. A single-institution retrospective study","volume":"23","author":"Kuku","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2007.05.048","article-title":"Adjuvant brachytherapy removes survival disadvantage of local disease extension in stage IIIC endometrial cancer: A SEER registry analysis","volume":"70","author":"Rossi","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib14","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ygyno.2016.04.010","article-title":"The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma","volume":"141","author":"Shaikh","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jso.23568","article-title":"Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program","volume":"109","author":"Mohanty","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib17","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1200\/JCO.1983.1.11.710","article-title":"Analysis of survival by tumor response","volume":"1","author":"Anderson","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.annepidem.2006.05.007","article-title":"Confounder selection in environmental epidemiology: Assessment of health effects of prenatal mercury exposure","volume":"17","author":"Budtz-Jorgensen","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2288-9-57","article-title":"Combining estimates of interest in prognostic modelling studies after multiple imputation: Current practice and guidelines","volume":"9","author":"Marshall","year":"2009","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib20","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1002\/sim.7048","article-title":"Multiple imputation of missing covariates for the Cox proportional hazards cure model","volume":"35","author":"Beesley","year":"2016","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: An overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Stat Med"},{"issue":"Pt 11","key":"10.1016\/j.ijrobp.2016.12.035_bib22","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1093\/brain\/awr061","article-title":"Multiple imputation models should incorporate the outcome in the model of interest","volume":"134","author":"Bartlett","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib23","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib25","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/pst.433","article-title":"Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies","volume":"10","author":"Austin","year":"2011","journal-title":"Pharm Stat"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib26","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: Results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib27","first-page":"179","article-title":"Factors predicting recurrent endometrial cancer","volume":"5","author":"Huijgens","year":"2013","journal-title":"Facts Views Vis Obgyn"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib28","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.ygyno.2005.03.008","article-title":"Predictors of vaginal relapse in stage I endometrial cancer","volume":"97","author":"Mariani","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2014.12.012","article-title":"Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study","volume":"136","author":"Elshaikh","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib30","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ygyno.2014.05.013","article-title":"Quantifying the risk of recurrence and death in stage III (FIGO 2009) endometrial cancer","volume":"134","author":"Milgrom","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib31","doi-asserted-by":"crossref","first-page":"e631","DOI":"10.1016\/j.ijrobp.2011.04.013","article-title":"Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma","volume":"81","author":"Creutzberg","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib32","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study","volume":"92","author":"Keys","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1200\/JCO.2004.00.7617","article-title":"Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: A Gynecologic Oncology Group Study","volume":"24","author":"Randall","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2014.04.008","article-title":"Adjuvant treatment and analysis of failures in patients with high-risk FIGO Stage Ib-II endometrial cancer: An Italian multicenter retrospective study (CTF study)","volume":"134","author":"Gadducci","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ygyno.2010.11.036","article-title":"Risk factors for poor prognosis in microinvasive adenocarcinoma of the uterine cervix (IA1 and IA2): A pooled analysis","volume":"121","author":"Hou","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fonc.2016.00036","article-title":"Disparities in gynecological malignancies","volume":"6","author":"Chatterjee","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2016.12.035_bib37","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/cncr.22997","article-title":"Descriptive nomograms of adjuvant radiotherapy use and patterns of care analysis for stage I and II endometrial adenocarcinoma: A Surveillance, Epidemiology, and End Results population study","volume":"110","author":"Lee","year":"2007","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.ijrobp.2016.12.035_bib38","first-page":"CD007585","article-title":"Lymphadenectomy for the management of endometrial cancer","author":"Frost","year":"2015","journal-title":"Cochrane Database Syst Rev"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616336252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301616336252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T07:28:42Z","timestamp":1536132522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301616336252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S0360301616336252"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.12.035","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2016.12.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}